Sign Up to like & get
recommendations!
1
Published in 2022 at "Journal of Enzyme Inhibition and Medicinal Chemistry"
DOI: 10.1080/14756366.2022.2046567
Abstract: Abstract This paper described our efforts to develop dianilinopyrimidines as novel EGFR inhibitors. All the target compounds were tested for inhibitory effects against wild type EGFR (EGFRwt) and three tumour cells, including A549, PC-3, and…
read more here.
Keywords:
design synthesis;
synthesis biological;
series dianilinopyrimidines;
biological evaluation ... See more keywords